{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:45:34Z","timestamp":1791312334575,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T00:00:00Z","timestamp":1466985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SATT Nord"},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique (CNRS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"R\u00e9gion Champagne-Ardenne"},{"name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche (FR)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10585-016-9803-0","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T08:27:46Z","timestamp":1467016066000},"page":"637-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide"],"prefix":"10.1007","volume":"33","author":[{"given":"Albin","family":"Jeanne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Boulagnon-Rombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Devy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Th\u00e9ret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Fichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bouland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Dani\u00e8le","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Martiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Dedieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,27]]},"reference":[{"key":"9803_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00018-007-7486-z","volume":"65","author":"S Kazerounian","year":"2008","unstructured":"Kazerounian S, Yee KO, Lawler J (2008) Thrombospondins in cancer. Cell Mol Life Sci 65:700\u2013712. doi: 10.1007\/s00018-007-7486-z","journal-title":"Cell Mol Life Sci"},{"key":"9803_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0038-1648509","volume":"67","author":"G Tuszynski","year":"1992","unstructured":"Tuszynski G, Smith M, Rothman V et al (1992) Thrombospondin levels in patients with malignancy. Thromb Haemost 67:607\u2013611","journal-title":"Thromb Haemost"},{"key":"9803_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jnci\/djj068","volume":"98","author":"GN Naumov","year":"2006","unstructured":"Naumov GN, Bender E, Zurakowski D et al (2006) A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 98:316\u2013325. doi: 10.1093\/jnci\/djj068","journal-title":"J Natl Cancer Inst"},{"key":"9803_CR4","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/onc.2014.228","volume":"34","author":"RS Watnick","year":"2015","unstructured":"Watnick RS, Rodriguez RK, Wang S et al (2015) Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells. Oncogene 34:2823\u20132835. doi: 10.1038\/onc.2014.228","journal-title":"Oncogene"},{"key":"9803_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jso.23037","volume":"106","author":"X-D Lin","year":"2012","unstructured":"Lin X-D, Chen S-Q, Qi Y-L et al (2012) Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma. J Surg Oncol 106:94\u2013100. doi: 10.1002\/jso.23037","journal-title":"J Surg Oncol"},{"key":"9803_CR6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0014-4827(89)90060-8","volume":"180","author":"BK McClenic","year":"1989","unstructured":"McClenic BK, Mitra RS, Riser BL et al (1989) Production and utilization of extracellular matrix components by human melanocytes. Exp Cell Res 180:314\u2013325","journal-title":"Exp Cell Res"},{"key":"9803_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0002-9440(10)61688-4","volume":"159","author":"O Straume","year":"2001","unstructured":"Straume O, Akslen LA (2001) Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am J Pathol 159:223\u2013235. doi: 10.1016\/S0002-9440(10)61688-4","journal-title":"Am J Pathol"},{"key":"9803_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851\u2013857. doi: 10.1038\/nature05661","journal-title":"Nature"},{"key":"9803_CR9","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/nm.3392","volume":"19","author":"P Lito","year":"2013","unstructured":"Lito P, Rosen N, Solit DB (2013) Tumor adaptation and resistance to RAF inhibitors. Nat Med 19:1401\u20131409. doi: 10.1038\/nm.3392","journal-title":"Nat Med"},{"key":"9803_CR10","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.18632\/oncotarget.2164","volume":"5","author":"A Jayachandran","year":"2014","unstructured":"Jayachandran A, Anaka M, Prithviraj P et al (2014) Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget 5:5782\u20135797","journal-title":"Oncotarget"},{"key":"9803_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1476-5381.2012.02099.x","volume":"167","author":"E Sick","year":"2012","unstructured":"Sick E, Jeanne A, Schneider C et al (2012) CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest. Br J Pharmacol 167:1415\u20131430. doi: 10.1111\/j.1476-5381.2012.02099.x","journal-title":"Br J Pharmacol"},{"key":"9803_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fphar.2015.00252","volume":"6","author":"A Jeanne","year":"2015","unstructured":"Jeanne A, Schneider C, Martiny L, Dedieu S (2015) Original insights on thrombospondin-1-related antireceptor strategies in cancer. Front Pharmacol 6:252. doi: 10.3389\/fphar.2015.00252","journal-title":"Front Pharmacol"},{"key":"9803_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/pcmr.12319","volume":"28","author":"P Borsotti","year":"2015","unstructured":"Borsotti P, Ghilardi C, Ostano P et al (2015) Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2. Pigment Cell Melanoma Res 28:73\u201381. doi: 10.1111\/pcmr.12319","journal-title":"Pigment Cell Melanoma Res"},{"key":"9803_CR14","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.18632\/oncotarget.4025","volume":"6","author":"A Jeanne","year":"2015","unstructured":"Jeanne A, Sick E, Devy J et al (2015) Identification of TAX2 peptide as a new unpredicted anti-cancer agent. Oncotarget 6:17981\u201318000","journal-title":"Oncotarget"},{"key":"9803_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8794-1-13","volume":"1","author":"AI Riker","year":"2008","unstructured":"Riker AI, Enkemann SA, Fodstad O et al (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1:13. doi: 10.1186\/1755-8794-1-13","journal-title":"BMC Med Genomics"},{"key":"9803_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/1535-7163.MCT-09-0764","volume":"9","author":"CK Augustine","year":"2010","unstructured":"Augustine CK, Jung S-H, Sohn I et al (2010) Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Mol Cancer Ther 9:779\u2013790. doi: 10.1158\/1535-7163.MCT-09-0764","journal-title":"Mol Cancer Ther"},{"key":"9803_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N et al (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603\u2013607. doi: 10.1038\/nature11003","journal-title":"Nature"},{"key":"9803_CR18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/nar\/gkg091","volume":"31","author":"A Brazma","year":"2003","unstructured":"Brazma A, Parkinson H, Sarkans U et al (2003) ArrayExpress\u2013a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 31:68\u201371","journal-title":"Nucleic Acids Res"},{"key":"9803_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR, Kalyana-Sundaram S, Mahavisno V et al (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166\u2013180","journal-title":"Neoplasia"},{"key":"9803_CR20","doi-asserted-by":"publisher","first-page":"420747","DOI":"10.1155\/2008\/420747","volume":"2008","author":"T Hruz","year":"2008","unstructured":"Hruz T, Laule O, Szabo G et al (2008) Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics 2008:420747. doi: 10.1155\/2008\/420747","journal-title":"Adv Bioinformatics"},{"key":"9803_CR21","doi-asserted-by":"publisher","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TS Keshava Prasad","year":"2009","unstructured":"Keshava Prasad TS, Goel R, Kandasamy K et al (2009) Human protein reference database\u20142009 update. Nucleic Acids Res 37:D767\u2013D772. doi: 10.1093\/nar\/gkn892","journal-title":"Nucleic Acids Res"},{"key":"9803_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J et al (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431\u2013432. doi: 10.1093\/bioinformatics\/btq675","journal-title":"Bioinformatics"},{"key":"9803_CR23","doi-asserted-by":"publisher","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","volume":"41","author":"K Breuer","year":"2013","unstructured":"Breuer K, Foroushani AK, Laird MR et al (2013) InnateDB: systems biology of innate immunity and beyond\u2013recent updates and continuing curation. Nucleic Acids Res 41:D1228\u20131233. doi: 10.1093\/nar\/gks1147","journal-title":"Nucleic Acids Res"},{"key":"9803_CR24","doi-asserted-by":"publisher","first-page":"D321","DOI":"10.1093\/nar\/gku1091","volume":"43","author":"G Launay","year":"2015","unstructured":"Launay G, Salza R, Multedo D et al (2015) MatrixDB, the extracellular matrix interaction database: updated content, a new navigator and expanded functionalities. Nucleic Acids Res 43:D321\u2013327. doi: 10.1093\/nar\/gku1091","journal-title":"Nucleic Acids Res"},{"key":"9803_CR25","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347:1260419. doi: 10.1126\/science.1260419","DOI":"10.1126\/science.1260419"},{"key":"9803_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymeth.2012.12.005","volume":"59","author":"SAI Seidel","year":"2013","unstructured":"Seidel SAI, Dijkman PM, Lea WA et al (2013) Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods 59:301\u2013315. doi: 10.1016\/j.ymeth.2012.12.005","journal-title":"Methods"},{"key":"9803_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1245\/ASO.2006.07.020","volume":"13","author":"L Kretschmer","year":"2006","unstructured":"Kretschmer L, Beckmann I, Thoms K-M et al (2006) Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma. Ann Surg Oncol 13:1105\u20131112. doi: 10.1245\/ASO.2006.07.020","journal-title":"Ann Surg Oncol"},{"key":"9803_CR28","doi-asserted-by":"publisher","first-page":"e11584","DOI":"10.1371\/journal.pone.0011584","volume":"5","author":"B Langlois","year":"2010","unstructured":"Langlois B, Perrot G, Schneider C et al (2010) LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS One 5:e11584. doi: 10.1371\/journal.pone.0011584","journal-title":"PLoS One"},{"key":"9803_CR29","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1128\/MCB.00228-12","volume":"32","author":"G Perrot","year":"2012","unstructured":"Perrot G, Langlois B, Devy J et al (2012) LRP-1\u2013CD44, a new cell surface complex regulating tumor cell adhesion. Mol Cell Biol 32:3293\u20133307. doi: 10.1128\/MCB.00228-12","journal-title":"Mol Cell Biol"},{"key":"9803_CR30","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1182\/blood-2009-09-242065","volume":"115","author":"A Zaslavsky","year":"2010","unstructured":"Zaslavsky A, Baek K-H, Lynch RC et al (2010) Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 115:4605\u20134613. doi: 10.1182\/blood-2009-09-242065","journal-title":"Blood"},{"key":"9803_CR31","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1096\/fj.09-131649","volume":"23","author":"X Zhang","year":"2009","unstructured":"Zhang X, Kazerounian S, Duquette M et al (2009) Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 23:3368\u20133376. doi: 10.1096\/fj.09-131649","journal-title":"FASEB J"},{"key":"9803_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.mvr.2014.02.005","volume":"98","author":"J-V Gaustad","year":"2015","unstructured":"Gaustad J-V, Simonsen TG, Andersen LMK, Rofstad EK (2015) Thrombospondin-1 domain-containing peptide properdistatin improves vascular function in human melanoma xenografts. Microvasc Res 98:159\u2013165. doi: 10.1016\/j.mvr.2014.02.005","journal-title":"Microvasc Res"},{"key":"9803_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrclinonc.2011.83","volume":"8","author":"K Bock De","year":"2011","unstructured":"De Bock K, Mazzone M, Carmeliet P (2011) Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat Rev Clin Oncol 8:393\u2013404. doi: 10.1038\/nrclinonc.2011.83","journal-title":"Nat Rev Clin Oncol"},{"key":"9803_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep01673","author":"S Kaur","year":"2013","unstructured":"Kaur S, Soto-Pantoja DR, Stein EV et al (2013) Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-myc and other stem cell transcription factors. Sci Rep. doi: 10.1038\/srep01673","journal-title":"Sci Rep"},{"key":"9803_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12079-015-0283-9","volume":"9","author":"DD Roberts","year":"2015","unstructured":"Roberts DD, Kaur S, Soto-Pantoja DR (2015) Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer. J Cell Commun Signal 9:101\u2013102. doi: 10.1007\/s12079-015-0283-9","journal-title":"J Cell Commun Signal"},{"key":"9803_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hep.27070","volume":"60","author":"TK-W Lee","year":"2014","unstructured":"Lee TK-W, Cheung VC-H, Lu P et al (2014) Blockade of CD47-mediated cathepsin S\/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. Hepatology 60:179\u2013191. doi: 10.1002\/hep.27070","journal-title":"Hepatology"},{"key":"9803_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.coi.2012.01.010","volume":"24","author":"MP Chao","year":"2012","unstructured":"Chao MP, Weissman IL, Majeti R (2012) The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 24:225\u2013232. doi: 10.1016\/j.coi.2012.01.010","journal-title":"Curr Opin Immunol"},{"key":"9803_CR38","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-14-2520","volume":"21","author":"MN McCracken","year":"2015","unstructured":"McCracken MN, Cha AC, Weissman IL (2015) Molecular pathways: activating t cells after cancer cell phagocytosis from blockade of CD47 \u201cDon\u2019t Eat Me\u201d signals. Clin Cancer Res 21:3597\u20133601. doi: 10.1158\/1078-0432.CCR-14-2520","journal-title":"Clin Cancer Res"},{"key":"9803_CR39","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/0008-5472.CAN-14-0037-T","volume":"74","author":"DR Soto-Pantoja","year":"2014","unstructured":"Soto-Pantoja DR, Terabe M, Ghosh A et al (2014) CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy. Cancer Res 74:6771\u20136783. doi: 10.1158\/0008-5472.CAN-14-0037-T","journal-title":"Cancer Res"},{"key":"9803_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000132568","volume":"29","author":"MJ Kim","year":"2008","unstructured":"Kim MJ, Lee J-C, Lee J-J et al (2008) Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines. Tumour Biol 29:28\u201334. doi: 10.1159\/000132568","journal-title":"Tumour Biol"},{"key":"9803_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/mt.2013.236","volume":"22","author":"T-Y Weng","year":"2014","unstructured":"Weng T-Y, Huang S-S, Yen M-C et al (2014) A novel cancer therapeutic using thrombospondin 1 in dendritic cells. Mol Ther 22:292\u2013302. doi: 10.1038\/mt.2013.236","journal-title":"Mol Ther"},{"key":"9803_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/nature15748","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S et al (2015) Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. doi: 10.1038\/nature15748","journal-title":"Nature"},{"key":"9803_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J et al (2015) Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527:525\u2013530. doi: 10.1038\/nature16064","journal-title":"Nature"},{"key":"9803_CR44","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ccell.2015.03.008","volume":"27","author":"E Hirata","year":"2015","unstructured":"Hirata E, Girotti MR, Viros A et al (2015) Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin \u03b21\/FAK signaling. Cancer Cell 27:574\u2013588. doi: 10.1016\/j.ccell.2015.03.008","journal-title":"Cancer Cell"},{"key":"9803_CR45","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1101\/gad.193501","volume":"15","author":"S Filleur","year":"2001","unstructured":"Filleur S, Volpert OV, Degeorges A et al (2001) In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. Genes Dev 15:1373\u20131382. doi: 10.1101\/gad.193501","journal-title":"Genes Dev"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-016-9803-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T03:42:03Z","timestamp":1568086923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-016-9803-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,27]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["9803"],"URL":"https:\/\/doi.org\/10.1007\/s10585-016-9803-0","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,27]]}}}